Clinical Trials Directory

Trials / Completed

CompletedNCT01744106

A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold

A Multicenter, Randomized, Placebo-Controlled Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
565 (actual)
Sponsor
Perrigo Company · Industry
Sex
All
Age
6 Years – 11 Years
Healthy volunteers
Not accepted

Summary

This study is designed to confirm the effectiveness of single-ingredient pseudoephedrine in children for the temporary relief of nasal congestion due to the common cold, an indication described under 21 CFR 341.80(b)(1).

Conditions

Interventions

TypeNameDescription
DRUGpseudoephedrine hydrochloride 30 mg tablets
DRUGPlacebo tablets

Timeline

Start date
2012-11-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2012-12-06
Last updated
2016-04-22

Locations

11 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01744106. Inclusion in this directory is not an endorsement.

A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold (NCT01744106) · Clinical Trials Directory